NMDA receptor antagonist-3
Product Specifications
UNSPSC Description
NMDA receptor antagonist-3, a NMDA receptor antagonist, stands out with a remarkable percentage of recovery (40.0%, at 100 μM) and safe toxicological profile in SH-SY5Y and human adipose mesenchymal stem cells.
Target Antigen
iGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel;Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/nmda-receptor-antagonist-3.html
Solubility
10 mM in DMSO
Smiles
O=C(CN)N1[C@@H](C2)CC[C@@H]2[C@@]1([H])C(N[C@H](C(O)=O)CC(O)=O)=O
Molecular Weight
313.31
References & Citations
[1]Sampaio-Dias IE, et al. Design, Synthesis, and Biological Evaluation of Hybrid Glypromate Analogues Using 2-Azanorbornane as a Prolyl and Pipecolyl Surrogate. ACS Chem Neurosci. 2021 Oct 6;12(19):3615-3624.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139708/NMDA-receptor-antagonist-3-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139708/
Clinical Information
No Development Reported
CAS Number
2762181-52-0
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items